Cooper Companies (COO) Expected to Post Quarterly Earnings on Wednesday

Cooper Companies (NASDAQ:COO) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, September 9th. Analysts expect Cooper Companies to post earnings of $1.12 per share and revenue of $1.0984 billion for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earning summary page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 5:00 PM ET.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $69.59 on Tuesday. The firm has a market capitalization of $13.57 billion, a P/E ratio of 58.97, a P/E/G ratio of 1.82 and a beta of 0.82. The firm’s 50-day moving average price is $72.67 and its 200-day moving average price is $70.28. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on COO shares. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Robert W. Baird reduced their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. BNP Paribas Exane decreased their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Stifel Nicolaus cut their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Finally, UBS Group began coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus price target of $81.64.

Institutional Trading of Cooper Companies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Cooper Companies by 48.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares in the last quarter. First Trust Advisors LP lifted its position in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after purchasing an additional 73,165 shares in the last quarter. Cresset Asset Management LLC purchased a new position in Cooper Companies during the second quarter worth about $291,000. Cerity Partners LLC boosted its holdings in Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. grew its position in Cooper Companies by 2.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.